Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.
about
HIV-1 superinfection in women broadens and strengthens the neutralizing antibody responseCondom use and high-risk sexual acts in adult films: a comparison of heterosexual and homosexual filmsGender differences in HIV-1 diversity at time of infectionEstimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study.Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate.Nanostructured optical photonic crystal biosensor for HIV viral load measurement.Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru.Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995.Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2.Screening for acute HIV infections and estimating HIV incidence among female sex workers from low-grade venues in Guangxi, China.Haemophilia therapy: assessing the cumulative risk of HIV exposure by cryoprecipitate.HIV serosorting as a harm reduction strategy: evidence from Seattle, WashingtonAnalysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variantsTaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.Risk of HIV infection from blood transfusion in Montreal.Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in CanadaDiagnostic virology.The investigation of patients with HIV infection: 10 years of progress.Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.HIV and STI risk behaviors, knowledge, and testing among female adult film performers as compared to other California women.A severe manifestation of primary HIV-1 infection in an adolescentResidual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.Making risk statements stick.Opportunistic infections--coming to the limits of immunosuppression?Patients with HIV infection and fever: a diagnostic approach.Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection.Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.In vitro affinity maturation and characterization of anti-P24 antibody for HIV diagnostic assay.Elimination of paediatric HIV in KwaZulu-Natal, South Africa: large-scale assessment of interventions for the prevention of mother-to-child transmission.Towards the prevention of transfusion-transmitted infectious diseases.Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors.Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1Estimating HIV incidence based on combined prevalence testing.Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.
P2860
Q21090490-1FDCEC12-200D-41E8-94C8-384F84E68E92Q24653815-0D616986-8D15-46C6-8A05-FD4180104871Q24706473-357FCF2F-F6D1-462B-80CD-324EF3C92E40Q30394281-8F798C93-5881-4DA1-B261-6251462A4979Q30433134-FDE696EE-337D-4A7A-A3E2-12A3CA58C940Q30442145-1B4980A1-987F-4D6E-9AD4-9162B99F71C1Q32026627-55E1485D-01EB-4B6A-8827-C4EC8DAAC850Q33459334-B8C9F14C-0E68-40EA-9867-C7AAF8A667EDQ33464763-0F2A6CAE-191C-4288-B53C-DFF29BB7653FQ33668746-D073137E-0E3A-42D3-ABE2-D7327BC87DCDQ33740610-A11EA8C7-D9B0-41EA-906C-542C66725D2DQ33785725-8E019D4B-8AB6-4913-AC08-51ABE2226556Q33917564-9C0752E2-E7CA-487F-B586-C1B93D61F5CAQ33965511-F55FE6C4-CDF2-42BD-BAB0-E4F55E7CC0F9Q33971576-C33FABA5-608C-4CF5-92D2-95248DB4096EQ33974221-7E3B29A2-58E6-4692-828D-725C9B034DECQ34025088-3DCDBBEA-0BCE-4306-B981-29AFEEDA1ACCQ34028746-C6919E95-A5DE-4A1C-AD70-59E21B7541CEQ34052588-DFA0D2E3-222E-4F89-945A-DC1F8A9B3657Q34140661-3F40B8D0-DD79-4A18-921D-087B6D2F0362Q34216522-2F186C80-BA62-4BF6-AC63-34975F562B41Q34234556-D75CAA4A-B6B7-4876-9D57-F43FC1F9E5C6Q34297326-C4F17918-6666-4A40-A75B-14B759345157Q34346207-ECD595F9-B5B2-4BD3-ADA3-A166D9E911C5Q34400923-A721088A-9E52-47D7-854B-FC4DA66EA9AEQ34941812-20138597-3568-4716-A323-B49A9267801CQ35004372-17310558-A246-4DA2-A691-765730764DB0Q35014909-1A21D237-D7D4-4EE2-88CF-037E8764E705Q35020912-304BA441-4806-49BC-B3EA-71FEDE14A4DDQ35032861-FD584443-24D2-4579-978C-C468BFBC5860Q35115540-CF71B7EA-E9A6-4C24-8EBA-E016AA223F55Q35688643-D7822377-7F7B-4DB1-B81B-62E96B64719FQ35857267-593E428F-1F75-4CE5-8B6C-7E4C470B0F22Q35917207-4ABDE6D3-8A54-41F7-8146-7B5DD2BBE8F2Q36078723-7A2B7412-509A-4099-BA01-E2BE91D32F85Q36220101-BED6D7AB-FED0-4523-B5D6-A7611FF9C38DQ36253005-AEC33AE1-C0B7-4FE4-8319-E4FA28161B96Q36253535-DBBB708E-74C4-45D2-889B-B7F12637474EQ36509600-05DC1E09-61B3-4795-AA47-62FAF7DF7F16Q36652701-02703BFD-CFC7-4011-93F2-529B278C4787
P2860
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Time course of detection of vi ...... ng of blood and tissue donors.
@en
Time course of detection of vi ...... ng of blood and tissue donors.
@nl
type
label
Time course of detection of vi ...... ng of blood and tissue donors.
@en
Time course of detection of vi ...... ng of blood and tissue donors.
@nl
prefLabel
Time course of detection of vi ...... ng of blood and tissue donors.
@en
Time course of detection of vi ...... ng of blood and tissue donors.
@nl
P2093
P1433
P1476
Time course of detection of vi ...... ng of blood and tissue donors.
@en
P2093
Farzadegan H
Henrard DR
Petersen LR
P356
10.1046/J.1537-2995.1995.35295125745.X
P577
1995-02-01T00:00:00Z